It was during closing arguments in a trial testing who had invented the antibody behind Abbott Laboratories’ hugely successful autoimmune drug, Humira. Defense attorney Bill Lee highlighted testimony by a researcher for rival Centocor Ortho Biotech Inc.
The researcher had acknowledged, Lee told the jurors, that unlike Abbott’s drug, Centocor’s wasn’t based on a completely human antibody. “He told you that it was never their intention to make a human antibody,” Lee said, according to the trial transcript.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
